Leuprorelin acetate Prescribing at MODALITY PARTNERSHIP (AWC)
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
741
Total Quantity
741
NHS Cost
£117.2K
vs National Avg
+1499%
MODALITY PARTNERSHIP (AWC) prescribed 741 items of Leuprorelin acetate over the last 12 months at a cost of £117,213 to the NHS. This is 1499% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jun 2026
54
Jun 2026
56
Jun 2026
52
Jun 2026
61
Jun 2026
63
Jun 2026
65
Jun 2026
60
Jun 2026
72
Jun 2026
78
Jun 2026
58
Jun 2026
64
Jun 2026
58
Prescribing Details
| Total Items | 741 |
|---|---|
| Total Quantity | 741 |
| Total NHS Cost | £117,213 |
| Presentations | 6 different forms |
| vs National Average | +1499% |
Leuprorelin acetate Prescribing Comparison
| This practice | 741 items |
|---|---|
| National average per practice | 46 items |
| Difference | +1499% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.